Lithopone

Titanium dioxide (TiO2) is a fine white powder or dust that occurs naturally. It was first intentionally produced for use as a white pigment in 1923.

In a 2017 study published in Scientific Reports, researchers exposed rats to human-relevant levels of E171 to examine the effects of intestinal inflammation and carcinogenesis. They saw that “a 100-day E171 treatment promoted colon microinflammation and initiated preneoplastic lesions while also fostering the growth of aberrant crypt foci in a chemically induced carcinogenesis model.” They continued: “Stimulation of immune cells isolated from Peyer’s Patches [which are clusters of lymphoid follicles found in the intestine] showed a decrease in Thelper (Th)-1 IFN-γ secretion, while splenic Th1/Th17 inflammatory responses sharply increased,” researchers wrote. “A 100-day titanium dioxide treatment promoted colon microinflammation and initiated preneoplastic lesions.” The scientists concluded: “These data should be considered for risk assessments of the susceptibility to Th17-driven autoimmune diseases and to colorectal cancer in humans exposed to TiO2 from dietary sources.”

One of the main challenges that manufacturers face when it comes to buff percentage is ensuring consistency. Variations in the level of coating on titanium dioxide particles can lead to differences in color, opacity, and other properties in the final product. This can be especially problematic in industries such as paint and coatings, where consistency is critical for achieving the desired results.